首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Analgesic synergism of gabapentin and carbamazepine in rat model of diabetic neuropathic pain
【24h】

Analgesic synergism of gabapentin and carbamazepine in rat model of diabetic neuropathic pain

机译:加巴喷丁和卡马西平在糖尿病性神经性疼痛大鼠模型中的镇痛协同作用

获取原文
           

摘要

Purpose: To evaluate synergy in the analgesic effects of a combination therapy of carbamazepine (CBZ) and gabapentin (GBP) in diabetic neuropathic pain. Methods: Neuropathic pain was produced in rats by a single intraperitoneal injection of streptozotocin (STZ) at 60 mg/kg. CBZ, GBP, and their combination were orally administered at varying doses (GBP 30 - 180 mg/kg; CBZ 20 - 40 mg/kg) comparable to their therapeutic doses in humans. Nociceptive responses in the diabetic rats were assessed using hot plate test. Results: Hot plate latency significantly increased with oral administration of GBP at a dose of 180 mg/kg when compared with control group (p 0.05). Conclusion: The results obtained in this study provide useful information on the combination therapy of GBP and CBZ, which may be applied in the treatment of pain in diabetic neuropathy.
机译:目的:评估卡马西平(CBZ)和加巴喷丁(GBP)联合治疗糖尿病性神经性疼痛的镇痛效果。方法:通过腹膜内注射60 mg / kg的链脲佐菌素(STZ),在大鼠中产生神经性疼痛。 CBZ,GBP及其组合以与人的治疗剂量相当的不同剂量(GBP 30-180 mg / kg; CBZ 20-40 mg / kg)口服。使用热板测试评估了糖尿病大鼠的伤害感受反应。结果:与对照组相比,口服给予GBP剂量为180 mg / kg的热板潜伏期显着增加(p 0.05)。结论:本研究结果为GBP和CBZ联合治疗提供了有用的信息,可用于糖尿病性神经病的疼痛治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号